Open-label MNS for Tourette Syndrome

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions
Tourette SyndromeTic Disorder, Chronic Motor or Vocal
Interventions
DEVICE

Active, self-directed electrical stimulation of the median nerve

Electrical stimulation of the median nerve (12 Hz, pulse width 200µs), initially at the threshold needed to see movement of the right thumb with stimulation. After initial training with the device and education in the rationale for suprathreshold stimulation, participants will choose timing and intensity of stimulation based on their momentary symptom severity and their experience with the treatment since the beginning of the study. Participant can choose right or left median nerve (we will suggest their nondominant hand to minimize interference with daily activities).

Trial Locations (1)

63110

Washington University School of Medicine, Movement Disorders Center, St Louis

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Washington University School of Medicine

OTHER

NCT05016765 - Open-label MNS for Tourette Syndrome | Biotech Hunter | Biotech Hunter